Aberrant cognitive phenotypes and altered hippocampal BDNF expression related to epigenetic modifications in mice lacking the post-synaptic scaffolding protein SHANK1: Implications for autism spectrum disorder

Hippocampus

Volumn 27, Issue 8, 2017, Pages 906-919

  Sungur, A Özge ^a   Jochner, Magdalena C E ^a   Harb, Hani ^a   Kılıç, Ayşe ^a   Garn, Holger ^a   Schwarting, Rainer K W ^a   Wöhr, Markus ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

acetylation; hippocampus; novel object recognition; social approach; social recognition

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DNA; HISTONE H3; SCAFFOLD PROTEIN; SHANK1 PROTEIN; UNCLASSIFIED DRUG; NERVE PROTEIN; SHANK1 PROTEIN, MOUSE;

ADULT; ADULTHOOD; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTISM; BODY WEIGHT; COGNITION; COMPARATIVE STUDY; CONTROLLED STUDY; DNA MODIFICATION; EPIGENETICS; FEMALE; GENETIC REGULATION; GENOTYPE; HIPPOCAMPUS; HISTONE ACETYLATION; LEARNING; LEFT HEMISPHERE; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECOGNITION; RIGHT HEMISPHERE; SNIFFING; SOCIAL BEHAVIOR; ANIMAL; C57BL MOUSE; COGNITIVE DEFECT; COMPLICATION; DEFICIENCY; DISEASE MODEL; GENETIC EPIGENESIS; GENETICS; KNOCKOUT MOUSE; METABOLISM; NEWBORN; PATHOLOGY; PERCEPTIVE DISCRIMINATION; PHYSIOLOGY; VOCALIZATION;

ANIMALS; ANIMALS, NEWBORN; AUTISM SPECTRUM DISORDER; BODY WEIGHT; BRAIN-DERIVED NEUROTROPHIC FACTOR; COGNITION DISORDERS; DISCRIMINATION (PSYCHOLOGY); DISEASE MODELS, ANIMAL; EPIGENESIS, GENETIC; HIPPOCAMPUS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; PHENOTYPE; RECOGNITION (PSYCHOLOGY); SOCIAL BEHAVIOR; VOCALIZATION, ANIMAL;

EID: 85023628430     PISSN: 10509631     EISSN: 10981063     Source Type: Journal    
DOI: 10.1002/hipo.22741     Document Type: Article

References (84)

1. Abdallah, M. W., Mortensen, E. L., Greaves-Lord, K., Larsen, N., Bonefeld-Jørgensen, E. C., Nørgaard-Pedersen, B., … Grove, J. (2013). Neonatal levels of neurotrophic factors and risk of autism spectrum disorders. Acta Psychiatrica Scandinavica, 128, 61–69.
2. Almeida, L. E. F., Roby, C. D., & Krueger, B. K. (2014). Increased BDNF expression in fetal brain in the valproic acid model of autism. Molecular Cell Neuroscience, 59, 57–62.
3. Amaral, D. G., Schumann, C. M., & Nordahl, C. W. (2008). Neuroanatomy of autism. Trends in Neuroscience, 31, 137–145.
4. American Psychiatric Association; APA. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.): DSM-5.
5. Antunes, M., & Biala, G. (2012). The novel object recognition memory: Neurobiology, test procedure, and its modifications. Cognitive Processing, 13, 93–110.
6. Balschun, D., Wetzel, W., Del Rey, A., Pitossi, F., Schneider, H., Zuschratter, W., & Besedovsky, H. O. (2004). Interleukin-6: A cytokine to forget. FASEB Journal, 18, 1788–1790.
7. Barde, Y. A., Edgar, D., & Thoenen, H. (1982). Purification of a new neurotrophic factor from mammalian brain. EMBO Journal, 1, 549–553.
8. Berkel, S., Marshall, C. R., Weiss, B., Howe, J., Roeth, R., Moog, U., … Rappold, G. A. (2010). Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nature Genetics, 42, 489–491.
9. Berkel, S., Tang, W., Treviño, M., Vogt, M., Obenhaus, H. A., Gass, P., … Rappold, G. A. (2012). Inherited and de novo SHANK2 variants associated with autism spectrum disorder impair neuronal morphogenesis and physiology. Human Molecular Genetics, 21, 344–357.
10. Bevins, R. A., & Besheer, J. (2006). Object recognition in rats and mice: A one-trial non-matching-to-sample learning task to study ‘recognition memory’. Nature Protocol, 1, 1306–1311.
11. Boeckers, T. M., Segger-Junius, M., Iglauer, P., Bockmann, J., Gundelfinger, E. D., Kreutz, M. R., … Kreienkamp, H. J. (2004). Differential expression and dendritic transcript localization of Shank family members: Identification of a dendritic targeting element in the 3′ untranslated region of Shank1 mRNA. Molecular Cell Neuroscience, 26, 182–190.
12. Boulle, F., van den Hove, D. L., Jakob, S. B., Rutten, B. P., Hamon, M., van Os, J., … Kenis, G. (2012). Epigenetic regulation of the BDNF gene: Implications for psychiatric disorders. Molecular Psychiatry, 17, 584–596.
13. Bourgeron, T. (2015). From the genetic architecture to synaptic plasticity in autism spectrum disorder. Nature Review Neuroscience, 16, 551–563.
14. Bredy, T. W., Wu, H., Crego, C., Zellhoefer, J., Sun, Y. E., & Barad, M. (2007). Histone modifications around individual BDNF gene promoters in prefrontal cortex are associated with extinction of conditioned fear. Learning and Memory, 14, 268–276.
15. Callaghan, C. K., & Kelly, A. M. (2013). Neurotrophins play differential roles in short and long-term recognition memory. Neurobiology Learning and Memory, 2013 104, 39–48.
16. Connolly, A. M., Chez, M., Streif, E. M., Keeling, R. M., Golumbek, P. T., Kwon, J. M., … Deuel, R. M. (2006). Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy. Biology and Psychiatry, 59, 354–363.
17. Correia, C. T., Coutinho, A. M., Sequeira, A. F., Sousa, I. G., Lourenço Venda, L., Almeida, J. P., … Vicente, A. M. (2010). Increased BDNF levels and NTRK2 gene association suggest a disruption of BDNF/TrkB signaling in autism. Genes, Brain and Behavior, 9, 841–848.
18. Cowansage, K. K., LeDoux, J. E., & Monfils, M. H. (2010). Brain-derived neurotrophic factor: A dynamic gatekeeper of neural plasticity. Current Molecular Pharmacology, 3, 12–29.
19. de la Torre-Ubieta, L., Won, H., Stein, J. L., & Geschwind, D. H. (2016). Advancing the understanding of autism disease mechanisms through genetics. Nature Medicine, 22, 345–361.
20. del Rey, A., Balschun, D., Wetzel, W., Randolf, A., & Besedovsky, H. O. (2013). A cytokine network involving brain-borne IL-1β, IL-1ra, IL-18, IL-6, and TNFα operates during long-term potentiation and learning. Brain Behavior and Immunity, 33, 15–23.
21. Dere, E., Huston, J. P., & De Souza Silva, M. A. (2007). The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents. Neuroscience and Biobehavioral Reviews, 31, 673–704.
22. Durand, C. M., Betancur, C., Boeckers, T. M., Bockmann, J., Chaste, P., Fauchereau, F., … Burglen, L. (2007). Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nature Genetics, 39, 25–27.
23. Ebert, D. H., & Greenberg, M. E. (2013). Activity-dependent neuronal signalling and autism spectrum disorder. Nature, 493, 327–337.
24. Ellegood, J., Anagnostou, E., Babineau, B. A., Crawley, J. N., Lin, L., Genestine, M., … Xuan, Z. (2015). Clustering autism: Using neuroanatomical differences in 26 mouse models to gain insight into the heterogeneity. Molecular Psychiatry, 20, 118–125.
25. Endres, T., & Lessmann, V. (2012). Age-dependent deficits in fear learning in heterozygous BDNF knock-out mice. Learning and Memory, 19, 561–570.
26. Epstein, I., Tushev, G., Will, T. J., Vlatkovic, I., Cajigas, I. J., & Schuman, E. M. (2014). Alternative polyadenylation and differential expression of Shank mRNAs in the synaptic neuropil. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences, 369, e20130137.
27. Filice, F., Vörckel, K. J., Sungur, A. Ö., Wöhr, M., & Schwaller, B. (2016). Reduction in parvalbumin expression not loss of the parvalbumin-expressing GABA interneuron subpopulation in genetic parvalbumin and shank mouse models of autism. Molecular Brain, 9, e10.
28. Fombonne, E. (1999). The epidemiology of autism: A review. Psychological Medicine, 29, 769–786.
29. Gauthier, J., Spiegelman, D., Piton, A., Lafrenière, R. G., Laurent, S., St-Onge, J., … Rouleau, G. A. (2009). Novel de novo SHANK3 mutation in autistic patients. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 150B, 421–424.
30. Grabrucker, A. M. (2014). A role for synaptic zinc in ProSAP/Shank PSD scaffold malformation in autism spectrum disorders. Developmental Neurobiology, 74, 136–146.
31. Guilmatre, A., Huguet, G., Delorme, R., & Bourgeron, T. (2014). The emerging role of SHANK genes in neuropsychiatric disorders. Developmental Neurobiology, 74, 113–122.
32. Harb, H., Amarasekera, M., Ashley, S., Tulic, M. K., Pfefferle, P. I., Potaczek, D. P., … Renz, H. (2015). Epigenetic regulation in early childhood: A miniaturized and validated method to assess histone acetylation. International Archives of Allergy and Immunology, 168, 173–181.
33. Hitti, F. L., & Siegelbaum, S. A. (2014). The hippocampal CA2 region is essential for social memory. Nature, 508, 88–92.
34. Hung, A. Y., Futai, K., Sala, C., Valtschanoff, J. G., Ryu, J., Woodworth, M. A., … Sheng, M. (2008). Smaller dendritic spines, weaker synaptic transmission, but enhanced spatial learning in mice lacking Shank1. Journal of Neuroscience, 28, 1697–1708.
35. Jiang, Y., & Ehlers, M. D. (2013). Modeling autism by SHANK gene mutations in mice. Neuron, 78, 8–27.
36. Koh, J.-Y., Lim, J., Byun, H.-R., & Yoo, M.-H. (2014). Abnormalities in the zinc-metalloprotease-BDNF axis may contribute to megalencephaly and cortical hyperconnectivity in young autism spectrum disorder patients. Molecular Brain, 7, e64.
37. Korte, M., Carroll, P., Wolf, E., Brem, G., Thoenen, H., & Bonhoeffer, T. (1995). Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proceedings of the National Academy of Sciences of the United States of America, 92, 8856–8860.
38. Leblond, C. S., Heinrich, J., Delorme, R., Proepper, C., Betancur, C., Huguet, G., … Skuse, D. (2012). Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders. PLoS Genetics, 8, e1002521.
39. Leblond, C. S., Nava, C., Polge, A., Gauthier, J., Huguet, G., Lumbroso, S., … Amsellem, F. (2014). Meta-analysis of SHANK mutations in autism spectrum disorders: A gradient of severity in cognitive impairments. PLoS Genetics, 10, e1004580.
40. Leibrock, J., Lottspeich, F., Hohn, A., Hofer, M., Hengerer, B., Masiakowski, P., … Barde, Y. A. (1989). Molecular cloning and expression of brain-derived neurotrophic factor. Nature, 341, 149–152.
41. Lennertz, L., Wagner, M., Wölwer, W., Schuhmacher, A., Frommann, I., Berning, J., … Mössner, R. (2012). A promoter variant of SHANK1 affects auditory working memory in schizophrenia patients and in subjects clinically at risk for psychosis. European Archives of Psychiatry and Clinical Neuroscience, 262, 117–124.
42. Li, J., Wilkinson, B., Clementel, V. A., Hou, J., O'dell, T. J., & Coba, M. P. (2016). Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome. Science Signal, 9, e8.
43. Louhivuori, V., Vicario, A., Uutela, M., Rantamäki, T., Louhivuori, L. M., Castrén, E., … Castrén, M. L. (2011). BDNF and TrkB in neuronal differentiation of Fmr1-knockout mouse. Neurobiology of Disease, 41, 469–480.
44. Martinowich, K., Hattori, D., Wu, H., Fouse, S., He, F., Hu, Y., … Sun, Y. E. (2003). DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science, 302, 890–893.
45. Masi, A., Quintana, D. S., Glozier, N., Lloyd, A. R., Hickie, I. B., & Guastella, A. J. (2015). Cytokine aberrations in autism spectrum disorder: A systematic review and meta-analysis. Molecular Psychiatry, 20, 440–446.
46. Miyazaki, K., Narita, N., Sakuta, R., Miyahara, T., Naruse, H., Okado, N., & Narita, M. (2004). Serum neurotrophin concentrations in autism and mental retardation: A pilot study. Brain and Development, 26, 292–295.
47. Moessner, R., Marshall, C. R., Sutcliffe, J. S., Skaug, J., Pinto, D., Vincent, J., … Scherer, S. W. (2007). Contribution of SHANK3 mutations to autism spectrum disorder. American Journal of Human Genetics, 81, 1289–1297.
48. Muñoz, P. C., Aspé, M. A., Contreras, L. S., & Palacios, A. G. (2010). Correlations of recognition memory performance with expression and methylation of brain-derived neurotrophic factor in rats. Biological Research, 43, 251–258.
49. Nelson, K. B., Grether, J. K., Croen, L. A., Dambrosia, J. M., Dickens, B. F., Jelliffe, L. L., … Phillips, T. M. (2001). Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Annals of Neurology, 49, 597–606.
50. Nickl-Jockschat, T., & Michel, T. M. (2011). The role of neurotrophic factors in autism. Molecular Psychiatry, 16, 478–490.
51. Papaleo, F., Silverman, J. L., Aney, J., Tian, Q., Barkan, C. L., Chadman, K. K., & Crawley, J. N. (2011). Working memory deficits, increased anxiety-like traits, and seizure susceptibility in BDNF overexpressing mice. Learning and Memory, 18, 534–544.
52. Park, H., & Poo, M. M. (2013). Neurotrophin regulation of neural circuit development and function. Nature Review Neuroscience, 14, 7–23.
53. Peça, J., Feliciano, C., Ting, J. T., Wang, W., Wells, M. F., Venkatraman, T. N., … Feng, G. (2011). Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature, 472, 437–442.
54. Petitto, J. M., McNamara, R. K., Gendreau, P. L., Huang, Z., & Jackson, A. J. (1999). Impaired learning and memory and altered hippocampal neurodevelopment resulting from interleukin-2 gene deletion. Journal of Neuroscience Research, 56, 441–446.
55. Pinto, D., Pagnamenta, A. T., Klei, L., Anney, R., Merico, D., Regan, R., … Bolton, P. F. (2010). Functional impact of global rare copy number variation in autism spectrum disorders. Nature, 466, 368–372.
56. Piskorowski, R. A., Nasrallah, K., Diamantopoulou, A., Mukai, J., Hassan, S. I., Siegelbaum, S. A., … Chevaleyre, V. (2016). Age-dependent specific changes in area CA2 of the hippocampus and social memory deficit in a mouse model of the 22q11.2 deletion syndrome. Neuron, 89, 163–176.
57. Radwan, B., Dvorak, D., & Fenton, A. A. (2016). Impaired cognitive discrimination and discoordination of coupled theta-gamma oscillations in Fmr1 knockout mice. Neurobiology of Disease, 88, 125–138.
58. Robinson, E. B., Lichtenstein, P., Anckarsäter, H., Happé, F., & Ronald, A. (2013). Examining and interpreting the female protective effect against autistic behavior. Proceedings of the National Academy of Sciences of the United States of America, 110, 5258–5262.
59. Sala, C., Piëch, V., Wilson, N. R., Passafaro, M., Liu, G., & Sheng, M. (2001). Regulation of dendritic spine morphology and synaptic function by Shank and Homer. Neuron, 31, 115–130.
60. Sala, C., Vicidomini, C., Bigi, I., Mossa, A., & Verpelli, C. (2015). Shank synaptic scaffold proteins: Keys to understanding the pathogenesis of autism and other synaptic disorders. Journal of Neurochemistry, 135, 849–858.
61. Santini, E., & Klann, E. (2014). Reciprocal signaling between translational control pathways and synaptic proteins in autism spectrum disorders. Science Signal, 7, e10.
62. Sato, D., Lionel, A. C., Leblond, C. S., Prasad, A., Pinto, D., Walker, S., … Stavropoulos, D. J. (2012). SHANK1 deletions in males with autism spectrum disorder. American Journal of Human Genetics, 90, 879–887.
63. Schmeisser, M. J., Ey, E., Wegener, S., Bockmann, J., Stempel, A. V., Kuebler, A., … Toro, R. (2012). Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2. Nature, 486, 256–260.
64. Schmeisser, M. J., & Verpelli, C. (2016). SHANK mutations in intellectual disability and autism spectrum disorder. Neuronal and Synaptic Dysfunction in Autism Spectrum Disorder and Intellectual Disability, 1, 151–160.
65. Silverman, J. L., Turner, S. M., Barkan, C. L., Tolu, S. S., Saxena, R., Hung, A. Y., … Crawley, J. N. (2011). Sociability and motor functions in Shank1 mutant mice. Brain Research, 1380, 120–137.
66. Studtmann, K., Olschläger-Schütt, J., Buck, F., Richter, D., Sala, C., Bockmann, J., … Kreienkamp, H. J. (2014). A noncanonical initiation site is required for efficient translation of the dendritically localized Shank1 mRNA. PLoS One, 9, e88518.
67. Sungur, A. Ö., Schwarting, R. K. W., & Wöhr, M. (2016). Early communication deficits in the Shank1 knockout mouse model for autism spectrum disorder: Developmental aspects and effects of social context. Autism Research, 9, 696–709.
68. Sungur, A. Ö., Vörckel, K. J., Schwarting, R. K. W., & Wöhr, M. (2014). Repetitive behaviors in the Shank1 knockout mouse model for autism spectrum disorder: Developmental aspects and effects of social context. Journal of Neurosci. Methods, 234, 92–100.
69. Szyf, M. (2015). Prospects for the development of epigenetic drugs for CNS conditions. Nature Review of Drug Discovery, 14, 461–474.
70. Tessarz, P., & Kouzarides, T. (2014). Histone core modifications regulating nucleosome structure and dynamics. Nature Review of Molecular Cell Biology, 15, 703–708.
71. Timmusk, T., Palm, K., Metsis, M., Reintam, T., Paalme, V., Saarma, M., & Persson, H. (1993). Multiple promoters direct tissue-specific expression of the rat BDNF gene. Neuron, 10, 475–489.
72. Ting, J. T., Peça, J., & Feng, G. (2012). Functional consequences of mutations in postsynaptic scaffolding proteins and relevance to psychiatric disorders. Annual Review of Neuroscience, 35, 49–71.
73. Uchino, S., & Waga, C. (2013). SHANK3 as an autism spectrum disorder-associated gene. Brain Development, 35, 106–110.
74. Valluy, J., Bicker, S., Aksoy-Aksel, A., Lackinger, M., Sumer, S., Fiore, R., … Schratt, G. (2015). A coding-independent function of an alternative Ube3a transcript during neuronal development. Nature Neuroscience, 18, 666–673.
75. Wang, T., Guo, H., Xiong, B., Stessman, H. A., Wu, H., Coe, B. P., … Eichler, E. E. (2016). De novo genic mutations among a Chinese autism spectrum disorder cohort. Nature Communication, 7, e13316.
76. Wang, X., McCoy, P. A., Rodriguiz, R. M., Pan, Y., Je, H. S., Roberts, A. C., … Jiang, Y. H. (2011). Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3. Human Molecular Genetics, 20, 3093–3108.
77. Wöhr, M. (2014). Ultrasonic vocalizations in Shank mouse models for autism spectrum disorders: Detailed spectrographic analyses and developmental profiles. Neuroscience Biobehavioral Review, 43, 199–212.
78. Wöhr, M., Orduz, D., Gregory, P., Moreno, H., Khan, U., Vörckel, K. J., … Schwaller, B. (2015). Lack of parvalbumin in mice leads to behavioral deficits relevant to all human autism core symptoms and related neural morphofunctional abnormalities. Translational Psychiatry, 5, e525.
79. Wöhr, M., Roullet, F. I., Hung, A. Y., Sheng, M., & Crawley, J. N. (2011). Communication impairments in mice lacking Shank1: Reduced levels of ultrasonic vocalizations and scent marking behavior. PLoS One, 6, e20631.
80. Wöhr, M., Silverman, J. L., Scattoni, M. L., Turner, S. M., Harris, M. J., Saxena, R., & Crawley, J. N. (2013). Developmental delays and reduced pup ultrasonic vocalizations but normal sociability in mice lacking the postsynaptic cell adhesion protein neuroligin2. Behavioral Brain Research, 251, 50–64.
81. Won, H., Lee, H. R., Gee, H. Y., Mah, W., Kim, J. I., Lee, J., … Kim, E. (2012). Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function. Nature, 486, 261–265.
82. Yang, M., Bozdagi, O., Scattoni, M. L., Wöhr, M., Roullet, F. I., Katz, A. M., … Crawley, J. N. (2012). Reduced excitatory neurotransmission and mild autism-relevant phenotypes in adolescent Shank3 null mutant mice. Journal of Neuroscience, 32, 6525–6541.
83. Yoo, J., Bakes, J., Bradley, C., Collingridge, G. L., & Kaang, B. K. (2013). Shank mutant mice as an animal model of autism. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences, 369, 20130143.
84. Zitzer, H., Honck, H. H., Bachner, D., Richter, D., & Kreienkamp, H. J. (1999). Somatostatin receptor interacting protein defines a novel family of multidomain proteins present in human and rodent brain. Journal of Biological Chemistry, 274, 32997–33001.